Kratom use and mental health: A systematic review
- PMID: 29248691
- DOI: 10.1016/j.drugalcdep.2017.10.012
Kratom use and mental health: A systematic review
Abstract
Background: Kratom (Mitragyna speciosa) is a psychoactive plant native to Southeastern Asia that is receiving increased international attention as a potential therapeutic agent. While much of the limited scientific research on kratom is focused on its analgesic potential, kratom use also has important risks and benefits in the domain of mental health.
Methods: We conducted a comprehensive systematic review of all studies on kratom use and mental health published between January 1960 and July 2017.
Results: Findings indicate kratom's potential as a harm reduction tool, most notably as a substitute for opioids among people who are addicted. Kratom also enhances mood and relieves anxiety among many users. For many, kratom's negative mental health effects - primarily withdrawal symptoms - appear to be mild relative to those of opioids. For some users, however, withdrawal is highly uncomfortable and maintaining abstinence becomes difficult.
Conclusion: Results inform clinicians working in the mental health and substance use fields, policy-makers, and researchers about the mental health effects of this plant.
Keywords: Harm reduction; Kratom; Mitragyna speciosa; Substitution.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2582. Epub 2017 May 24. Hum Psychopharmacol. 2017. PMID: 28544011 Review.
-
Pharmacologic and clinical assessment of kratom.Am J Health Syst Pharm. 2018 Mar 1;75(5):261-267. doi: 10.2146/ajhp161035. Epub 2017 Dec 18. Am J Health Syst Pharm. 2018. PMID: 29255059 Review.
-
Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.J Ethnopharmacol. 2018 Mar 25;214:197-206. doi: 10.1016/j.jep.2017.12.017. Epub 2017 Dec 15. J Ethnopharmacol. 2018. PMID: 29248450
-
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.Subst Abuse Treat Prev Policy. 2023 Apr 11;18(1):21. doi: 10.1186/s13011-023-00531-4. Subst Abuse Treat Prev Policy. 2023. PMID: 37041624 Free PMC article.
-
Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia.J Psychoactive Drugs. 2015 Apr-Jun;47(2):125-31. doi: 10.1080/02791072.2015.1012610. J Psychoactive Drugs. 2015. PMID: 25950592
Cited by
-
Kratom-Induced Psychiatric Decompensation and Paranoid Delusions.Cureus. 2024 Feb 21;16(2):e54626. doi: 10.7759/cureus.54626. eCollection 2024 Feb. Cureus. 2024. PMID: 38524086 Free PMC article.
-
Knowledge of Kratom among Alabama Pharmacists.Pharmacy (Basel). 2023 Dec 30;12(1):6. doi: 10.3390/pharmacy12010006. Pharmacy (Basel). 2023. PMID: 38251400 Free PMC article.
-
Kratom withdrawal: Discussions and conclusions of a scientific expert forum.Drug Alcohol Depend Rep. 2023 Mar 15;7:100142. doi: 10.1016/j.dadr.2023.100142. eCollection 2023 Jun. Drug Alcohol Depend Rep. 2023. PMID: 37397437 Free PMC article. No abstract available.
-
Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain.Life Sci. 2023 Sep 1;328:121878. doi: 10.1016/j.lfs.2023.121878. Epub 2023 Jun 29. Life Sci. 2023. PMID: 37392779
-
Kratom's Emergence and Persistence Within the US Polydrug Epidemic.Curr Addict Rep. 2023;10(2):262-271. doi: 10.1007/s40429-023-00476-5. Epub 2023 Apr 18. Curr Addict Rep. 2023. PMID: 37266191 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
